Antecedents to and outcomes of medical emergency team calls in haematology patients
Abbey Willcox, Emily See, Andrew Lim, Daryl Jones
0 citationsInternal Medicine Journal
Andrew Lim
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
43Publications signalées
1052Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Hematopoietic Stem Cell TransplantationMultiple Myeloma Research and TreatmentsAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia research
Publications récentes
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome
Ray Mun Koo, Eric Wong, Joanne E. Davis, Travis Perera et autres
0 citationsBone Marrow Transplantation
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome
Ray Mun Koo, Eric Wong, Joanne E. Davis, Travis Perera et autres
0 citationsResearch Square
Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high‐risk cytogenetics: IKEMA subgroup analysis
Ivan Špıčka, Philippe Moreau, Thomas G. Martin, Thierry Façon et autres
24 citationsEuropean Journal Of Haematology
Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft‐versus‐host disease prophylaxis following allogeneic haemopoietic cell transplantation
Radha Ramanan, Andrew Lim, Joanne Tan, Rahul Barmanray et autres
0 citationsInternal Medicine Journal
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis
Thierry Façon, Philippe Moreau, Thomas G. Martin, Ivan Špıčka et autres
18 citationsHematological Oncology
Impact of a policy to improve the management of oral medications when patients are fasting before a procedure: an interrupted time series analysis
The‐Phung To, Sabine Braat, Andrew Lim, Jo‐anne E Brien et autres
2 citationsBMJ Open Quality
Inferior Outcomes for Multiple Myeloma (MM) Patients (pts) Harbouring t(11;14) and the Promise of Venetoclax, Real-World Australian Retrospective
Kenneth J C Lim, Dipti Talaulikar, Joanne Tan, Joanna Loh et autres
1 citationBlood
P-217: Isatuximab plus Carfilzomib and Dexamethasone in relapsed Multiple Myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis
Ivan Špıčka, Philippe Moreau, Thomas Martin, Thierry Façon et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
P-051: Inferior outcomes for Multiple Myeloma (MM) patients (pts) harbouring t(11;14) and the promise of venetoclax, real-world Australian retrospective
Kenneth J C Lim, Dipti Talaulikar, Joanne Tan, Joanna Loh et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
MM-092: Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Elderly Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis
Thierry Façon, Philippe Moreau, Thomas G. Martin, Ivan Špıčka et autres
2 citationsClinical Lymphoma Myeloma & Leukemia
Poster: MM-092: Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Elderly Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis
Thierry Façon, Philippe Moreau, Thomas G. Martin, Ivan Špıčka et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.